Inventor

TILSTAM ULF

DE7 patents

⚠️ This page may combine multiple inventors who share the name “TILSTAM ULF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

3 patents

US5386028AJan 31, 1995

Process for the production of N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and their metal complexes

SCHERING AG33 citations91

US6046322AApr 4, 2000

Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%

SCHERING AG12 citations72

US6784292B2Aug 31, 2004

Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof

SCHERING AG2 citations59

CONTEXT BIOPHARMA INC

2 patents

US10308676B2Jun 4, 2019

Methods of making onapristone intermediates

CONTEXT BIOPHARMA INC1 citations56

US11613555B2Mar 28, 2023

Methods for onapristone synthesis dehydration and deprotection

CONTEXT BIOPHARMA INC0 citations52

BAYER SCHERING PHARMA AG

1 patent

US7547776B1Jun 16, 2009

Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%

BAYER SCHERING PHARMA AG2 citations61

GRAWE DETLEF

1 patent

US8324412B2Dec 4, 2012

Method for preparing 4-[17β-methoxy-17α-methoxymethyl-3-oxoestra-4,9-dien-11β-yl]benzaldehyde (E)-oxime (asoprisnil)

GRAWE DETLEF0 citations30